Get the Stockscreener App
2.39
0.84%
0.02
After Hours:
2.39
Harvard Bioscience Inc stock is traded at $2.39, with a volume of 95,898.
It is up +0.84% in the last 24 hours and down -0.42% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
See More
Previous Close:
$2.37
Open:
$2.37
24h Volume:
95,898
Relative Volume:
0.91
Market Cap:
$103.80M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-18.38
EPS:
-0.13
Net Cash Flow:
$10.81M
1W Performance:
-2.45%
1M Performance:
-0.42%
6M Performance:
-37.92%
1Y Performance:
-44.42%
1-Day Range:
$2.35
$2.42
1-Week Range:
$2.34
$2.49
52-Week Range:
$2.30
$5.56
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Is It Too Late To Consider Buying Harvard Bioscience, Inc. (NASDAQ:HBIO)? - Yahoo Finance
Zacks Industry Outlook Highlights Mettler-Toledo International and Harvard Bioscience - Yahoo Finance
Harvard Bioscience (HBIO) Set to Announce Earnings on Thursday - MarketBeat
Moolec Science (MLEC) versus Its Rivals Head-To-Head Comparison - Defense World
Chegg, Inc. (NYSE:CHGG) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET - The Manila Times
2 Instruments Stocks to Watch From a Challenging Industry - Yahoo Finance
HBIO stock touches 52-week low at $2.31 amid market challenges - Investing.com India
Electroporation Instruments Market Analysis by Trends, - openPR
HBIO stock touches 52-week low at $2.33 amid market challenges - Investing.com Australia
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives - GuruFocus.com
Harvard Bioscience Inc (HBIO) Q2 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Laboratory Centrifuge Market Innovations Investigated by Insights: Technological Advancements and Market Gr... - WhaTech
Institutional owners may take dramatic actions as Harvard Bioscience, Inc.'s (NASDAQ:HBIO) recent 12% drop adds to one-year losses - Simply Wall St
Annual Sustainability Report - Harvard University
Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m - Pharmaceutical Technology
HBIO stock touches 52-week low at $2.49 amid market challenges By Investing.com - Investing.com South Africa
HBIO stock touches 52-week low at $2.49 amid market challenges - Investing.com
HBIO Stock Drops Amidst Market Fluctuations - GuruFocus.com
Harvard Biosciences to Appear at Chicago Meeting - Baystreet.ca
Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024 - The Manila Times
SPDR S&P Retail ETF (NYSEARCA:XRT) Stock Position Decreased by Renaissance Technologies LLC - Defense World
Compugen Ltd. (NASDAQ:CGEN) Shares Sold by Renaissance Technologies LLC - Defense World
Renaissance Technologies LLC Sells 11,300 Shares of SEACOR Marine Holdings Inc. (NYSE:SMHI) - Defense World
Microfluidics Market Innovations Investigated by Report Strategies, Forecast - WhaTech
The past three years for Harvard Bioscience (NASDAQ:HBIO) investors has not been profitable - Yahoo Finance
ACAD: 3 Healthcare Stocks Analysts Expect to Rally Over 50% - StockNews.com
Artificially Intelligent Stethoscope Market Current Scenario and Future Prospects|Eko Devices, Littmann Stethoscopes - Daily Invest News
272 Capital LP Has $4.38 Million Holdings in Harvard Bioscience, Inc. (NASDAQ:HBIO) - MarketBeat
Laboratory Colorimeter Market By Sources Analysis, Share, Trends, Size, Forecast From (2024-2034) - Third Eye News
Immunohematology Market Growth Revenue, Industry Demand Report To 2033 - WhaTech
Global Perfusion Systems Market Innovations Investigated by Trends and Outlook 2024 - WhaTech
FLO stock rated an Underperform by Exane BNP Paribas - Knox Daily
Harvard’s latest medical innovation advances 3D printed blood vessels - 3D Printing Industry
Long Term Trading Analysis for (THRD) - Stock Traders Daily
Harvard Bioscience stock hits 52-week low at $2.6 - Investing.com
United States Turbidity Instruments Market Size, Share, Trends, Growth, Analysis & Forecast - Third Eye News
Electroporator Industry – Market Insights and Growth Potential - Elektrotransports.lv
United States UV Spectrophotometer Market Size, Share, Trends, Growth, Analysis & Forecast - Third Eye News
Harvard’s Wyss Creates New Way to 3D Print Blood Vessels—Moves Closer to Artificial Organs - 3DPrint.com
Harvard Bioscience to showcase solutions for preclinical, organoid applications - TipRanks
Harvard Bioscience to Showcase Latest Solutions for - GlobeNewswire
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting - Marketscreener.com
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development - Benzinga
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology - Financial Times
Sidoti Events, LLC's Virtual September Small-Cap Conference - Yahoo Finance
Life Science And Chemical Instrumentation Market Size, Share, Trends, Demand, Forecast To 2033 - WhaTech Technology and Markets News
Electroporation Technology Market is thriving worldwide by 2031 - Elektrotransports.lv
United States Telemetry Implant Market By Application - Third Eye News
Acadian Asset Management LLC Buys 41,520 Shares of Woori Financial Group Inc. (NYSE:WF) - Defense World
Private Advisor Group LLC Purchases 14,574 Shares of Invesco S&P 500 Momentum ETF (NYSEARCA:SPMO) - Defense World
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Harvard Bioscience Inc Stock (HBIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Green James W | Chief Executive Officer |
Jun 06 '24 |
Buy |
3.07 |
20,000 |
61,400 |
3,101,091 |
0.98%
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):